4.7 Article

Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality

Related references

Note: Only part of the references are listed.
Article Immunology

Resolvins suppress tumor growth and enhance cancer therapy

Megan L. Sulciner et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

RvD1 inhibits TNFα-induced c-Myc expression in normal intestinal epithelial cells and destabilizes hyper-expressed c-Myc in colon cancer cells

Xiancai Zhong et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Review Pathology

New Roles of Cyclin D1

Richard G. Pestell

AMERICAN JOURNAL OF PATHOLOGY (2013)

Review Pharmacology & Pharmacy

Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders

Ha-Na Lee et al.

BIOCHEMICAL PHARMACOLOGY (2012)

Review Biochemistry & Molecular Biology

Interleukin-6-A Key Regulator of Colorectal Cancer Development

Maximilian J. Waldner et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)

Article Medicine, Research & Experimental

ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice

Mathew C. Casimiro et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Article Biochemistry & Molecular Biology

Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangements

Andrew J. Holland et al.

NATURE MEDICINE (2012)

Article Biochemistry & Molecular Biology

Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE

Stephanie M. Puetz et al.

MOLECULAR CANCER (2010)

Article Multidisciplinary Sciences

Resolvin D1 binds human phagocytes with evidence for proresolving receptors

Sriram Krishnamoorthy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Editorial Material Oncology

Inflammation and Cancer: IL-6 and STAT3 Complete the Link

Jacqueline Bromberg et al.

CANCER CELL (2009)

Article Pharmacology & Pharmacy

Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus

C. N. Serhan et al.

BRITISH JOURNAL OF PHARMACOLOGY (2008)

Review Multidisciplinary Sciences

Origin and physiological roles of inflammation

Ruslan Medzhitov

NATURE (2008)

Article Medicine, Research & Experimental

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland

Pasquale Sansone et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Gastroenterology & Hepatology

DNA ploidy status and prognosis in colorectal cancer: A meta-analysis of published data

Sergio E. A. Araujo et al.

DISEASES OF THE COLON & RECTUM (2007)

Article Biochemistry & Molecular Biology

Colitis and colitis-associated cancer are exacerbated in mice deficient for tumor protein 53-induced nuclear protein 1

Julien Gommeaux et al.

MOLECULAR AND CELLULAR BIOLOGY (2007)

Article Biochemistry & Molecular Biology

Cyclin D1 determines mitochondrial function in vivo

Toshiyuki Sakamaki et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Review Immunology

Interleukin-6 trans-signalling in chronic inflammation and cancer

J Scheller et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2006)

Review Oncology

Centrosomal amplification and spindle multipolarity in cancer cells

W Saunders

SEMINARS IN CANCER BIOLOGY (2005)

Article Biochemistry & Molecular Biology

Short term cyclin D1 overexpression induces centrosome amplification, mitotic spindle abnormalities, and aneuploidy

CJ Nelsen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Review Endocrinology & Metabolism

Minireview: Cyclin D1: Normal and abnormal functions

MF Fu et al.

ENDOCRINOLOGY (2004)

Article Multidisciplinary Sciences

Hexameric structure and assembly of the interleukin-6/IL-6 α-receptor/gp130 complex

MJ Boulanger et al.

SCIENCE (2003)

Review Oncology

To cycle or not to cycle: A critical decision in cancer

M Malumbres et al.

NATURE REVIEWS CANCER (2001)

Article Gastroenterology & Hepatology

Family history as a risk factor for colorectal cancer in inflammatory bowel disease

J Askling et al.

GASTROENTEROLOGY (2001)